Clinical trial
INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study
NCT02104882 · Universitätsmedizin Mannheim, Other · Completed
Key facts
| NCT number | NCT02104882 |
|---|---|
| Title | INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study |
| Official title | INTRAGO-Intraoperative Radiotherapy for Glioblastoma - a Phase I/II Study |
| Lead sponsor | Universitätsmedizin Mannheim, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Glioblastoma Multiforme |
| Intervention type | Radiation |
| Interventions | Intraoperative Radiotherapy (Applicator Surface Dose: 20-40 Gy) |
| Enrollment | 12 |
| Start date | Mar 1, 2014 |
| Primary completion | Sep 1, 2016 |
| Completion | Sep 1, 2016 |
| First posted | Apr 7, 2014 |
| Last update posted | Oct 17, 2016 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: